Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Ultragenyx stock
Learn how to easily invest in Ultragenyx stock.
Ultragenyx is a biotechnology business based in the US. Ultragenyx shares (RARE) are listed on the NASDAQ and all prices are listed in US Dollars. Ultragenyx employs 1,119 staff and has a trailing 12-month revenue of around $334.3 million.
How to buy shares in Ultragenyx
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RARE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Ultragenyx stock price (NASDAQ: RARE)Use our graph to track the performance of RARE stocks over time.
Ultragenyx shares at a glance
|Latest market close||$41.41|
|52-week range||$40.84 - $91.10|
|50-day moving average||$50.07|
|200-day moving average||$63.12|
|Wall St. target price||$111.76|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-6.87|
Buy Ultragenyx shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Ultragenyx stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ultragenyx price performance over time
|1 week (2022-09-23)||-0.22%|
|1 month (2022-09-02)||-13.28%|
|3 months (2022-07-01)||-33.90%|
|6 months (2022-03-29)||N/A|
|1 year (2021-10-01)||-52.84%|
|2 years (2020-10-02)||-50.94%|
|3 years (2019-10-02)||42.22|
|5 years (2017-09-29)||53.26|
|Revenue TTM||$334.3 million|
|Gross profit TTM||$-161,755,000|
|Return on assets TTM||-20.76%|
|Return on equity TTM||-61.32%|
|Market capitalisation||$2.9 billion|
TTM: trailing 12 months
Ultragenyx share dividends
We're not expecting Ultragenyx to pay a dividend over the next 12 months.
Have Ultragenyx's shares ever split?
Ultragenyx's shares were split on a 1:3 basis on 17 January 2014. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ultragenyx shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Ultragenyx shares which in turn could have impacted Ultragenyx's share price.
Ultragenyx share price volatility
Over the last 12 months, Ultragenyx's shares have ranged in value from as little as $40.84 up to $91.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ultragenyx's is 1.2189. This would suggest that Ultragenyx's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for treating long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidatures include DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome; UX701, for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co. , Ltd.
Ultragenyx in the news
Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR
Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR
Frequently asked questionsWhat percentage of Ultragenyx is owned by insiders or institutions?
Currently 5.033% of Ultragenyx shares are held by insiders and 94.299% by institutions. How many people work for Ultragenyx?
Latest data suggests 1,119 work at Ultragenyx. When does the fiscal year end for Ultragenyx?
Ultragenyx's fiscal year ends in December. Where is Ultragenyx based?
Ultragenyx's address is: 60 Leveroni Court, Novato, CA, United States, 94949 What is Ultragenyx's ISIN number?
Ultragenyx's international securities identification number is: US90400D1081 What is Ultragenyx's CUSIP number?
Ultragenyx's Committee on Uniform Securities Identification Procedures number is: 90400D108
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert